This wearable robotic garment suit, the MyoSuit, is an innovative functional training device, for patients with mobility impairments, designed to allow a more intensive gait-, strength- and endurance training. Visit them at stand N7072. @myoswiss
The team @StanleyHandling is on countdown to @Naidex where they will be
launching their new mobility ramps on stand N5101. Read more here
https://t.co/JXBuvOHEjD
#Naidex45#WeAreAble
“#MCTD and #yoga is a perfect combination because you can use all the aspects of yoga to help you manage the disease”: https://t.co/Z04wOxLJUd @BeeContentYoga #spoonie#chronicillness#painmanagement
Friends - PLEASE SHARE for my friend Jill & her daughter Kylie: .
@TheEllenShow spending her childhood coping with pain most can't imagine. It's a serious illness - Stiff Person Syndrome, odds of diagnosis are about one in a million... https://t.co/9qyRRzph6l via @YouTube
“Unlike death, when you have a #chronicillness, you can heal. You may not, but you can, and I believe it is perfectly alright to hold onto that #hope – In fact, I believe it is paramount to the #healing process”: https://t.co/t1Br5YjuBX @CallieDixon #normal#acceptance
I suffer from rare neurological autoimmune disease called stiff person syndrome. It affects one in 1 million people. There is no cure! Was diagnosed at UCSF in 1994 when severe spasms my legs and back kept me... https://t.co/7a4NyMlZyF
Rare Disease UK are the official organisers of Rare Disease Day in the UK. Registration is now open for this year’s receptions. Why not read about last year’s events here: https://t.co/fbY7eLrwON #raredisease
Where’s #RareDisease in the #NHS10yearplan? You’ll need to dig deep..point
3.115 states whole genome sequencing will be widely available, vital to better & earlier diagnosis. But a huge opportunity to support the 3.5k with rare in the UK has been missed https://t.co/s23flCzIxG
Did you know you can now donate to the Rare Disease UK campaign through our website? You can make a one off or monthly donations. Find out more here: https://t.co/DGq2mntPQ7